Dynacure
unite phase trial to evaluate safety tolerability and signs of efficacy in patients | Dynacure
Company
Deck Type
IPO
Deck date
July 2021
Slide
17 of 33
Related slides by other companies
AstraZeneca
Results
November 2024
inhibitor i | AstraZeneca
BioNTech
Results
March 2021
designed to overcome limitations of therapy | BioNTech
NeuroSense Therapeutics
Investor Presentation
June 2023
phase a trial design | NeuroSense Therapeutics
Immatics
Investor Presentation
November 2023
phase clinical trial to evaluate targeting | Immatics
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io